50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,719.04
DOW   29,683.74
QQQ   279.94
Mullen Automotive Is Ready To Get In Gear
Sell every Stock except ONE (Ad)
You Don't Have to Go It Alone. It's Time to Let Go and Let Others Help.
Cracker Barrel: A Tasty Treat Or Bad Apple? 
Sell every Stock except ONE (Ad)
Alzheimer's drug shows promise in early results of study
Can United Natural Foods Fight Both Inflation and the Fed?
Capitalize On the $499 Billion Invested in Commercial Real Estate (Ad)pixel
Bank of England to buy UK bonds to avert financial risk
Russia prepares to annex occupied Ukraine despite outcry
S&P 500   3,719.04
DOW   29,683.74
QQQ   279.94
Mullen Automotive Is Ready To Get In Gear
Sell every Stock except ONE (Ad)
You Don't Have to Go It Alone. It's Time to Let Go and Let Others Help.
Cracker Barrel: A Tasty Treat Or Bad Apple? 
Sell every Stock except ONE (Ad)
Alzheimer's drug shows promise in early results of study
Can United Natural Foods Fight Both Inflation and the Fed?
Capitalize On the $499 Billion Invested in Commercial Real Estate (Ad)pixel
Bank of England to buy UK bonds to avert financial risk
Russia prepares to annex occupied Ukraine despite outcry
S&P 500   3,719.04
DOW   29,683.74
QQQ   279.94
Mullen Automotive Is Ready To Get In Gear
Sell every Stock except ONE (Ad)
You Don't Have to Go It Alone. It's Time to Let Go and Let Others Help.
Cracker Barrel: A Tasty Treat Or Bad Apple? 
Sell every Stock except ONE (Ad)
Alzheimer's drug shows promise in early results of study
Can United Natural Foods Fight Both Inflation and the Fed?
Capitalize On the $499 Billion Invested in Commercial Real Estate (Ad)pixel
Bank of England to buy UK bonds to avert financial risk
Russia prepares to annex occupied Ukraine despite outcry
S&P 500   3,719.04
DOW   29,683.74
QQQ   279.94
Mullen Automotive Is Ready To Get In Gear
Sell every Stock except ONE (Ad)
You Don't Have to Go It Alone. It's Time to Let Go and Let Others Help.
Cracker Barrel: A Tasty Treat Or Bad Apple? 
Sell every Stock except ONE (Ad)
Alzheimer's drug shows promise in early results of study
Can United Natural Foods Fight Both Inflation and the Fed?
Capitalize On the $499 Billion Invested in Commercial Real Estate (Ad)pixel
Bank of England to buy UK bonds to avert financial risk
Russia prepares to annex occupied Ukraine despite outcry
LON:IKA

Ilika - IKA Share Forecast, Price & News

GBX 57
0.00 (0.00%)
(As of 09/29/2022 03:38 AM ET)
Add
Compare
Today's Range
55
57
50-Day Range
53
85.81
52-Week Range
42.03
203
Volume
6,533 shs
Average Volume
224,665 shs
Market Capitalization
£89.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
GBX 247.50
IKA stock logo

About Ilika (LON:IKA) Stock

Ilika plc engages in the design, development, and production of solid-state batteries under the Stereax name primarily in the United Kingdom, Asia, rest of Europe, and North America. It offers batteries for a range of applications in the industrial Internet of Things, medical, transportation, electric vehicles, and cordless consumer electronics/ smart cities. The company was founded in 2004 and is headquartered in Romsey, the United Kingdom.

Receive IKA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ilika and its competitors with MarketBeat's FREE daily newsletter.

IKA Stock News Headlines

Ilika plc (ILIKF)
Ilika starts manufacturing equipment trials for Goliath battery cells
See More Headlines
Receive IKA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ilika and its competitors with MarketBeat's FREE daily newsletter.

IKA Company Calendar

Last Earnings
7/11/2019
Today
9/29/2022

Industry, Sector and Symbol

Industry
Electronic Components
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
51
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
GBX 247.50
High Stock Price Forecast
GBX 250
Low Stock Price Forecast
GBX 245
Forecasted Upside/Downside
+334.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£496,103.00
Cash Flow
GBX 14.42 per share
Book Value
GBX 19.90 per share

Miscellaneous

Free Float
N/A
Market Cap
£89.90 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Graeme Purdy (Age 57)
    CEO & Exec. Director
    Comp: $285.89k
  • Mr. Stephen John Boydell (Age 51)
    Company Sec. & Exec. Director
    Comp: $171.46k
  • Paul Marron
    Technology Transfer Director













IKA Stock - Frequently Asked Questions

Should I buy or sell Ilika stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ilika in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" IKA shares.
View IKA analyst ratings
or view top-rated stocks.

What is Ilika's stock price forecast for 2022?

2 analysts have issued 12-month price objectives for Ilika's shares. Their IKA share price forecasts range from GBX 245 to GBX 250. On average, they predict the company's share price to reach GBX 247.50 in the next twelve months. This suggests a possible upside of 334.2% from the stock's current price.
View analysts price targets for IKA
or view top-rated stocks among Wall Street analysts.

How have IKA shares performed in 2022?

Ilika's stock was trading at GBX 181.50 at the beginning of 2022. Since then, IKA stock has decreased by 68.6% and is now trading at GBX 57.
View the best growth stocks for 2022 here
.

How were Ilika's earnings last quarter?

Ilika plc (LON:IKA) announced its quarterly earnings data on Thursday, July, 11th. The company reported ($2.42) EPS for the quarter, missing the consensus estimate of ($2.40) by $0.02.

What other stocks do shareholders of Ilika own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ilika investors own include Inseego (INSG), Nanoco Group (NANO), Akoustis Technologies (AKTS), Niu Technologies (NIU), CRISPR Therapeutics (CRSP), NVIDIA (NVDA), Tencent (TCEHY), Alibaba Group (BABA), Charlotte's Web (CWBHF) and JD.com (JD).

What is Ilika's stock symbol?

Ilika trades on the London Stock Exchange (LON) under the ticker symbol "IKA."

How do I buy shares of Ilika?

Shares of IKA stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Ilika's stock price today?

One share of IKA stock can currently be purchased for approximately GBX 57.

How much money does Ilika make?

Ilika (LON:IKA) has a market capitalization of £89.90 million and generates £496,103.00 in revenue each year.

How can I contact Ilika?

Ilika's mailing address is Kenneth Dibben House, Enterprise Road, SOUTHAMPTON, SO16 7NS, United Kingdom. The official website for the company is www.ilika.com. The company can be reached via phone at +44-23-80111400.

This page (LON:IKA) was last updated on 9/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.